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The prevalence of glomerular hyperfiltration in type 2
diabetic patients varies widely. Here we studied whether
glomerular hyperfiltration in diabetic nephropathy in type 2
patients is related to renal structural changes and predicts
the functional development of diabetic nephropathy. Thirty
normo- or microalbuminuric type 2 diabetic patients having
a renal biopsy were followed every 6 months for a mean
of 6.2 years. The glomerular filtration rate (GFR) at the time
of biopsy, determined by iohexol clearance, correlated with
filtration surface per glomerulus, but no other quantitative
microscopic morphometric parameter. The filtration surface
was positively associated with the decrease in GFR during the
first year but not associated in subsequent years following
the renal biopsy. The GFR showed a statistically significant
linear decrease in 9 of the 30 patients; however, slopes of the
regression lines were almost zero in 11 patients. The GFR
increased and decreased in a parabolic manner in two
patients. Seven of the nine patients with a statistically
significant decline in renal function did not show any
appreciable worsening of albuminuria, while two patients
developed persistent proteinuria. Thus, in renal biopsy-
proven normo- or microalbuminuric type 2 diabetic patients,
glomerular hyperfiltration is closely associated with an
increased glomerular filtration surface. An elevated GFR
predicts its subsequent decline, which may occur without
worsening of albuminuria.
Kidney International (2012) 81, 486–493; doi:10.1038/ki.2011.404;
published online 7 December 2011
KEYWORDS: albuminuria; diabetic glomerulopathy; diabetic nephropathy;
glomerular hyperfiltration
Various studies have shown that glomerular hyperfiltra-
tion occurs in type 1 (refs 1–7) and type 2 diabetes.8–15
Approximately one-third of type 1 diabetic patients without
overt nephropathy have a glomerular filtration rate (GFR)
above the upper normal limit of age-adjusted healthy
subjects.5 Glomerular hyperfiltration occurs in B65% of
young type 1 diabetic patients,7 and has been regarded as a
predisposing factor for albuminuria in type 1 diabetes.4,6
Recent meta-analysis using 780 type 1 diabetic patients has
also shown that individuals with glomerular hyperfiltration
were at risk for the progression of diabetic nephropathy.16
Microalbuminuria is also an indicator that predicts a
rapid decline of GFR.17 In contrast to type 1 diabetes, the
prevalence of glomerular hyperfiltration reported in type 2
diabetic patients varies widely from 7 to 73%.8,10,12,13 In
addition, in type 2 diabetes, microalbuminuria is associated
with a faster decline of GFR.18 Pima Indians’ type 2 diabetic
patients showed an increased GFR at the onset, and
then maintained normoalbuminuria for over 10 years. After
this time, type 2 diabetic Pima Indians showed a decreased
GFR with the development of microalbuminuria, resulting
in an accelerated progression after development of overt
proteinuria.19 The ADVANCE study also demonstrated
that low GFR and high albuminuria are independent risk
factors for renal events in patients with type 2 diabetes,
although less reliable serum creatinine–based estimated
GFR was used in this analysis.20 Glomerular hyperfiltration
occurs at the normoalbuminuric or microalbuminuric
stages, whereas GFR may decline after clinical proteinuria
has manifested in both type 1 and 2 diabetic patients.
However, there are difficulties involved in defining the
exact roles for microalbuminuria and glomerular hyperfiltra-
tion in predicting the progression of diabetic nephropathy
in type 2 diabetes, as renal structural changes per se could
derive from nondiabetic causes, and individual GFR varies
depending on factors including age.21 Type 1 diabetic
patients with glomerular hyperfiltration showed renal func-
tion decline,4,6 and the risk for early progressive decline in
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renal function increased when they had microalbuminuria.17
In type 2 diabetes, however, it remains controversial whether
glomerular hyperfiltration is followed by subsequent GFR
decline.22–24
Renal structural–functional relationships have been des-
cribed thoroughly for type 1 diabetes.25–27 Urinary albumin
excretion (UAE) paralleled with mesangial expansion,25,26
whereas the GFR correlated positively with the filtration
surface of the glomerulus.28 However, in type 2 diabetes,
although glomerular hyperfiltration was observed in 17% of
the patients with relatively poor glycemic control,29 little is
known about the relationships between renal structural
changes and GFR. To elucidate renal structural–functional
relationships in the early stage of diabetic nephropathy in
type 2 diabetes, we performed a detailed analysis of renal
morphology and its relationship with GFR. Finally, we
studied whether glomerular hyperfiltration can predict
further functional changes.
RESULTS
Clinical characteristics and laboratory findings
Baseline clinical characteristics between the diabetic and
control groups such as age, body mass index, systolic, and
diastolic blood pressure did not show any differences
(Table 1). Diabetic patients had a hemoglobin A1c (HbA1c)
value of 8.2±1.8%, GFR of 118±28ml/min per 1.73m2,
and kidney volume of 158±35ml. Their mean UAE was
8.3 mg/min; 20 patients were normoalbuminuric and 10 were
microalbuminuric. In all, 17 patients had diabetic retino-
pathy: 11 had simple retinopathy, and 6 had preproliferative
or proliferative retinopathy. None required antihypertensives
at the initial evaluation. However, one normoalbuminuric
and four microalbuminuric patients were prescribed angio-
tensin II receptor blockers during the observation period.
The level of albuminuria in five cases did not change and
microalbuminuria in four cases did not return to normo-
albuminuria during the observation period, although angio-
tensin II receptor blockers were prescribed (data not shown).
The HbA1c and blood pressure at the end of the observation
period did not show any significant change from the baseline
levels (data not shown).
Morphometric analysis and renal structural–functional
relationships in the diabetic patients
Renal morphometry findings of the 30 diabetic patients
were compatible with early diabetic nephropathy, although
Table 1 | Demographic data, clinical characteristics, and renal
function of the diabetic patients and the normal control
subjects
Diabetic patients Controls P-value
Male/female 22/8 2/7 ND
Age (years) 49±9 51±8 NS
Known duration (years) 12±7 — ND
BMI (kg/m2) 22.5±2.5 23.0±2.7 NS
GFR (ml/min per 1.73m2) 118±28 — ND
SBP (mmHg) 119±16 110±6 NS
DBP (mmHg) 73±12 69±5 NS
DMR (N/S/P) 12/11/6 — ND
Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; DMR, diabetic
retinopathy; GFR, glomerular filtration rate; N, none; ND, not done; NS, not
significant; P, preproliferative–proliferative retinopathy; S, simple retinopathy;
SBP, systolic blood pressure.
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Figure 1 |Relationship between the glomerular filtration rate (GFR) and electron microscopic morphometry. In total, 30 type 2
diabetic patients without nondiabetic renal histological changes were measured for their GFR using iohexol injection. The surface density
of the peripheral glomerular basement membrane (Sv(PGBM/glom)) (a) and the volume fraction of the mesangium (Vv(Mes/glom))
(b) were compared with the baseline GFR data. The straight line in a indicates a statistically significant linear regression line
(GFR¼ 449.2 Sv(PGBM/glom)þ 68.6; r¼ 0.54; Po0.01).
Table 2 |Morphometric analysis of the diabetic patients and
the normal control subjects
Diabetic patients Controls P-value
MGV ( 106mm3) 3.1±0.8 1.4±0.5 o0.0001
%GS 7.2±12.7 7.5±9.7 NS
Vv(Int/cortex) 0.21±0.05 0.10±0.01 o0.0001
GBM width (nm) 713±117 296±43 o0.0001
Vv(Mes/glom) 0.25±0.07 0.19±0.03 0.021
Sv(PGBM/glom) (mm2/mm3) 0.11±0.03 0.12±0.02 NS
Total Mes/glom ( 106mm3) 0.76±0.27 0.27±0.10 o0.0001
Filtration S/G (mm2) 0.35±0.14 0.17±0.04 o0.001
Abbreviations: Filtration S/G, filtration surface per glomerulus; GBM, glomerular
basement membrane; %GS, percent glomerular sclerosis; MGV, mean glomerular
volume; NS, not significant; Sv(PGBM/glom), surface density of peripheral GBM; total
Mes/glom, total mesangium per glomerulus; Vv(Int/cortex), volume fraction of
interstitium; Vv(Mes/glom), volume fraction of mesangium.
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20 of them remained normoalbuminuric at the time of renal
biopsy (Table 2). Mean glomerular volume (MGV), inter-
stitial volume fraction (Vv(Int/cortex)), glomerular basement
membrane (GBM) width, volume fraction of mesangium
(Vv(Mes/glom)), total mesangium per glomerulus (total
Mes/glom), and filtration surface per glomerulus (filtration
S/G) were markedly higher in the diabetic patients than
in the controls, whereas percent glomerular sclerosis and
the surface density of peripheral GBM (Sv(PGBM/glom)) did
not show a significant difference between the two groups.
Sv(PGBM/glom) (n¼ 30, r¼ 0.54, Po0.01; Figure 1a) and
filtration S/G (r¼ 0.44, Po0.05) were significantly positively
correlated with GFR at biopsy. None of the other morpho-
metric parameters, including Vv(Mes/glom) (Figure 1b) and
total Mes/glom, significantly correlated with GFR.
The time course of the GFR change
The GFR was determined 7.8±4.2 (refs 2–18) times per
patient during the follow-up period. Multiple regression
analyses using all measured GFR values of the 30 patients
revealed that they showed a gradual but significant decrease
as a function of time (Figure 2; GFR¼0.195monthþ
128.128; r¼ 0.23; P¼ 0.0003), revealing an average annual
GFR decline rate of 2.3ml/min per 1.73m2. Twenty-two
patients underwent more than five GFR measurements,
which allowed for statistical analysis. Linear regression
analysis revealed that nine of these patients showed a signi-
ficant linear decrease with an average annual GFR decline rate
of 4.9ml/min per 1.73m2 (Figure 3a). In two patients,
the time courses of the GFR profile were parabolic and fit
statistically to a quadratic function opening downward with a
peak GFR value detected during the observation period,
followed by a subsequent decrease (Figure 3b). Regression
analysis of the remaining 11 patients did not reach any
statistically significant increment or decline of GFR (Figure
3c). Of the nine patients showing a steady decline of GFR,
seven patients did not show any appreciable worsening of
albuminuria, whereas only two patients developed persistent
proteinuria as their renal function impairment progressed
(Figure 3a). To unravel any morphometric parameters to
predict future decline of renal function, we compared
morphometric data between the 9 patients whose GFR
showed a significant decrease and the 11 patients whose GFR
remained unaltered. None of the morphometric values
revealed any difference between the two groups, including
GBM width (732±106 vs. 669±125), Vv(Mes/glom)
(0.26±0.05 vs. 0.22±0.08), or Sv(PGBM/glom) (0.09±
0.03 vs. 0.12±0.04).
The detection of parameters associated with the GFR decline
We further analyzed whether any of the above structural
and functional parameters in early diabetic nephropathy
are associated with renal function decline. None of the
following parameters showed any correlation with the GFR
decline during the subsequent year: kidney volume, MGV,
GBM width, Vv(Mes/glom), total Mes/glom, and filtration S/G.
In contrast, the Sv(PGBM/glom) value negatively correlated
with the yearly change of GFR following the renal biopsy
(n¼ 24, r¼0.42; Po0.05; Figure 4a). However, the
negative correlation between Sv(PGBM/glom) and the GFR
change disappeared when analyzed using the GFR change
during the longer periods of time; i.e., the GFR change
during the 5-year period subsequent to renal biopsy did not
show any correlation with Sv(PGBM/glom) (n¼ 14, not
significant; Figure 4b).
We next examined whether the GFR value is associated
with a subsequent reduction in GFR because Sv(PGBM/
glom), which theoretically reflects the pathophysiology of
hyperfiltration, negatively correlated with the GFR values at
biopsy, and was associated with the subsequent GFR decline.
The GFR value showed a close negative correlation with the
annual change in GFR (n¼ 73, r¼0.25; Po0.05; Figure 5),
suggesting that the elevated GFR resulted in a significantly
decreased value in the subsequent year. To determine whether
a higher GFR likely results in the GFR decrease, we
performed receiver operating characteristic analysis to obtain
a cutoff value that discriminates between decliners and non-
decliners. Receiver operating characteristic curves were
plotted using serial cutoff data for GFR, revealing that a
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Figure 2 |Relationship between the glomerular filtration
rate (GFR) of the patients and the time after renal biopsy.
All GFR values at baseline and follow-up periods were plotted
sequentially. The straight line in the panel denotes a linear
regression line of all GFR values (GFR¼0.195monthþ
128.128; r¼ 0.23; P¼ 0.0003).
Figure 3 | Serial changes of the glomerular filtration rate (GFR) and urinary albumin excretion (UAE) in 22 patients who underwent
at least five GFR follow-up measurements. The GFR values showed a significant linear decrease in 9 patients (a), a parabolic increase
followed by a decrease in 2 patients (b), and no significant increment or decline of the GFR in 11 patients (c). Closed circles represent
individual GFR values plotted against the time after the renal biopsy. Open, shadowed, and closed horizontal panels at the top of each
panel represent the period showing normoalbuminuria, microalbuminuria, or overt proteinuria, respectively.
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cutoff value equal to or higher than 134ml/min per 1.73m2
significantly separates decliners and non-decliners. The
greatest area under curve of 0.62165 (Po0.03) was obtained
when the cutoff value for GFR was set at 134–136ml/min per
1.73m2, with a sensitivity of 42%, a specificity of 88%, and
annual GFR decline rate of 3.2–3.7ml/min per 1.73m2. The
results are consistent with the notion that an elevated GFR
predicts subsequent GFR decline.
The negative association of the GFR decline with HbA1c,
blood pressure, or UAE
Finally, we analyzed whether the GFR change in early diabetic
nephropathy is associated with conventional factors known
to accelerate renal impairment. UAE at biopsy neither
showed a significant correlation with GFR at biopsy
(Figure 6a) nor with the GFR change during the subsequent
1-year period (Figure 6b) and 5-year period (Figure 6c),
suggesting that the UAE value did not predict further
GFR decline. HbA1c or blood pressure was not
significantly correlated with the GFR at biopsy either (data
not shown).
DISCUSSION
One of the major obstacles that has prevented elucidation of
accurate clinical courses and structural–functional relation-
ships of early diabetic nephropathy in type 2 diabetes was the
heterogeneity of renal structures compared with type 1
diabetic patients.30–33 In the present study, we have recruited
patients least likely having factors inducing nondiabetic renal
injury from a large population of outpatients, and established
the sole diagnosis of early diabetic nephropathy on the basis
of renal histology in our 30 type 2 diabetic patients. The
study procedures allowed the analyses of structural–func-
tional relationships and renal functional outcomes. The
diabetic patients had far greater MGV, wider GBM, and
enlarged Vv(Mes/glom) and Vv(Int/cortex) than controls.
These results are similar to those described in type 1 diabetes,
in which Sv(PGBM/glom) and filtration S/G were correlated
with GFR and glomerular hyperfiltration that resulted from
elevated glomerular surface area.28,34 In type 2 diabetes, the
relationship between GFR and renal structural abnormalities
has remained unclear despite the occurrence of glomer-
ular hyperfiltration.8–12,14–16,24,35 In the present study, we
describe the positive correlation between Sv(PGBM/glom) or
filtration S/G and GFR at the early stage of diabetic
nephropathy in type 2 diabetes. These data demonstrate that
glomerular hyperfiltration is also associated with the enlarged
Sv(PGBM/glom) or filtration S/G in type 2 diabetes as in
type 1 diabetes.
In the present study, we disclose that Sv(PGBM/glom)
demonstrated a significant positive correlation with GFR at
the time of the renal biopsy. Furthermore, Sv(PGBM/glom)
showed a negative correlation with the GFR change during
the 1-year period after renal biopsy, but did not correlate
with the GFR change during the longer follow-up periods.
These data suggest that histological morphometry data such
as Sv(PGBM/glom) could change during the course of
diabetes and would not predict the longitudinal prognosis
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Figure 4 |Correlation between the surface density of peripheral glomerular basement membrane (Sv(PGBM/glom)) and the change
in the glomerular filtration rate (GFR) during the subsequent year. Sv(PGBM/glom) was measured using the line intercept method and
plotted against the change in GFR values obtained from the difference between the GFR measured at the renal biopsy and at 1 year (a) or 5
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(GFR) value and subsequent GFR change during the 1-year
period. All GFR values measured at the renal biopsy and at follow-
up after the renal biopsy were plotted against the GFR change
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of GFR. Other morphometric parameters, including Vv(Mes/
glom), neither correlated with GFR at renal biopsy nor
predicted the long-standing GFR decline. A previous study
showed that mesangial expansion correlated with decreased
renal function and urinary protein excretion in type 2
diabetes.36 Mesangial expansion occurred markedly at the
overt proteinuric stage, although Vv(Mes/glom) values
were slightly increased in both normoalbuminuric and
microalbuminuric type 2 diabetic patients.37 Our current
results demonstrate that the GFR change and Vv(Mes/glom)
values were not associated in incipient diabetic nephropathy.
Therefore, Sv(PGBM/glom) may be a more predictive indi-
cator of renal function than mesangial expansion at the early
stage of nephropathy in type 2 diabetes.
As microalbuminuria proceeds the GFR decline in
diabetes,4,17 it is likely a risk factor for renal function decline.
In the present study, however, UAE did not show any
correlation with the GFR value, nor did it predict the GFR
decline in the near future. Furthermore, the great majority
of patients who showed a statistically significant decline of
renal function during the observation period did not show
any appreciable worsening of albuminuria. This suggests an
independent progression of albuminuria and renal function.
These results argue against the role of UAE as a predictor of
deteriorating renal function in type 2 diabetes. A recent
prospective study using type 1 diabetic patients showed that
glomerular hyperfiltration defined using serum cystatin
C–based estimated GFR did not influence the development
of albuminuria even after 15 years of follow-up.38 Further-
more, a faster GFR decline preceded the microalbuminuria,39
whereas a progressive decline of GFR occurred in the absence
of the UAE increase in type 1 diabetes.40 Our current results
agree with these recent data on type 1 diabetes that UAE is
not a reliable indicator for progression of renal function in
type 2 diabetes.
A remarkable finding of the current study is that
glomerular hyperfiltration, when accurately determined using
iohexol clearance, correlated significantly with GFR decrease
during the subsequent year. Consistent with these findings,
the Sv(PGBM/glom) value, which best reflects GFR,
was closely associated with the GFR decline during the
subsequent year. Previous reports examining whether glo-
merular hyperfiltration in type 2 diabetes predicts future
deterioration of renal function reached contrasting conclu-
sions.23,24 Our results using biopsy-proven diabetic nephro-
pathy support the study that glomerular hyperfiltration
showed a faster decline of GFR.23 Thus, glomerular
hyperfiltration itself has a higher predictive value for renal
function decline than UAE does.
Our iohexol-based GFRs showed close correlation with
inulin clearance.29 The average coefficient of variation
determined by repeated measurements was 10.3±3.1%
(mean±s.d.; n¼ 16), which may display day-to-day vari-
ability plus measurement error. Despite the variability
associated with iohexol-based GFR data, our sequential
measurements revealed a statistically significant linear decline
in patients with high baseline GFR values. The annual rate of
GFR decrease of our decliners was higher than the entire
panel of patients (4.9 vs. 2.3ml/min per 1.73m2), and far
greater than the age-related natural course of less than
1ml/min per year.14 Further, our receiver operating charac-
teristic analysis to determine whether the decline in GFR is
more evident in patients with higher GFRs revealed a GFR
cutoff value of 134ml/min per 1.73m2, which significantly
discriminated between GFR decliners and non-decliners.
A lower cutoff GFR value could not distinguish between
decliners and non-decliners. These data suggest that GFR
decline in our high GFR patients were unlikely because of the
regression to the mean.
In conclusion, in the normoalbuminuric and micro-
albuminuric type 2 diabetic patients with a definite
histological diagnosis of diabetic nephropathy, increased
glomerular filtration surface reflects an elevated GFR that
results in a declined GFR in the following year. However,
UAE is not related to glomerular hyperfiltration or to the
GFR decline in the early stage of diabetic nephropathy in type
2 diabetic patients.
MATERIALS AND METHODS
Type 2 diabetic patients
Since 1998, normotensive type 2 diabetic patients without overt
proteinuria, hematuria, or renal dysfunction and without any
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Kidney International (2012) 81, 486–493 491
T Moriya et al.: Renal structure and GFR in type 2 diabetes o r ig ina l a r t i c l e
evidence suggesting atherosclerotic diseases were recruited at the
outpatient clinic of Kitasato University Hospital. Patients who were
excluded from this initial recruitment were patients receiving
antihypertensive drugs; with a past history of any malignant,
cerebrovascular, or cardiovascular diseases; and with recurrent
infection. Patients were fully informed about the trial, and 41
Japanese type 2 diabetic patients who consented to participate
received percutaneous renal biopsies at Kitasato University Hospital.
Of these 41 patients, 11 were excluded after the renal biopsy results
were examined. One patient was excluded because of insufficient
biopsy material for an accurate diagnosis, and the remaining
10 patients revealed evident immunoglobulin A nephropathy with
or without diabetic changes. The remaining 30 patients showed no
evidence of nondiabetic renal glomerular or tubular/interstitial
changes. There were 8 women and 22 men (49±9 years) with a
known diabetic duration of 12±7 years. The normoalbuminuria
was defined as a UAE less than 20 mg/min, whereas microalbumin-
uria was defined as a UAE between 20 and 200 mg/min using 4-h
collected urine samples at the GFR measurement described below.
Clinical examinations were conducted along with the renal biopsy
and semi-annually after the renal biopsy. The protocol for this study
was approved by the Research Ethics Committee of Kitasato
University School of Medicine.
Normal control subjects
The renal biopsy reference values of normal controls were
obtained from nine living renal transplant donors (two men and
seven women; age 51±8 years) 1 h after transplantation as
described.39 All nine subjects showed normal 75 g oral glucose
tolerance test results, negative dipstick proteinuria, and normal
blood pressure.
Laboratory and clinical measurements
HbA1c was measured by high-performance liquid chromato-
graphy. The value for HbA1c (%) was estimated as the National
Glycohemoglobin Standardization Program (NGSP) equivalent
value (%) calculated by the formula HbA1c (%)¼HbA1c (the
Japan Diabetes Society; JDS)(%)þ 0.4%, considering the relational
expression of HbA1c (JDS)(%) measured by the previous Japanese
standard substance and measurement methods and HbA1c
(NGSP).41 The GFR was measured by the plasma clearance of
unlabeled iohexol.29,42,43 Briefly, 5ml iohexol (3235mg) was injected
intravenously and blood samples were drawn 2, 3, and 4 h after the
injection. The plasma concentration of iohexol was measured by
HPLC, and the GFRs were calculated with the slope of the terminal
plasma disappearance curve of iohexol in the Central Laboratory in
the Kitasato University Hospital. Urinary albumin was measured by
turbidimetric immunoassay using 4-h collected urine at the GFR
measurement. Microalbuminuria or overt nephropathy was defined
when the 4-h prompt-collected urine reached 20 mg/min or 200 mg/
min in two consecutive determinations, respectively, and the initial
time exceeding the value was defined as the change of albuminuria
stage. Kidney volume was measured by a helical computed
tomography scan and was expressed in milliliters. Blood pressure
was measured during the initial hospitalization and at the
outpatient visit. Hypertension was defined as systolic blood pressure
X130mmHg, diastolic blood pressure X85mmHg, and/or
patients receiving treatment with antihypertensive drugs. During
the follow-up period, patients developing hypertension were
prescribed antihypertensives to achieve optimal blood pressure
control (under 130/80mmHg).
Morphometric analysis of renal biopsies
For light microscopic morphometric analysis, renal biopsy tissues
from both diabetic patients and controls were fixed in 10% buffered
formalin and stained with periodic acid-Schiff stain. The MGV was
determined on the light microscopic sections at an approximate
magnification of  150 using the point counting method of Weibel
and Gometz.44 At least 15 glomerular profiles (24±10, mean±s.d.)
for each patient were measured. Percent glomerular sclerosis was
measured as described previously.45 Interstitial volume fraction
(Vv(Int/cortex)) was determined on the light microscopic sections
at an approximate magnification of  300 by point counting images
projected onto a white surface with a projection microscope.46
For electron microscopic morphometric analysis, kidney tissues
were cut into cubes (B1mm3), fixed in 2.5% glutaraldehyde in
0.1M cacodylate buffer (pH 7.4), and postfixed in osmium
tetroxide. These specimens were dehydrated in graded series of
ethanol and embedded in Quetol 812 (Nissin EM, Tokyo, Japan). All
specimens were cut into thick and 8090 nm ultrathin sections and
studied using a JEOL CX 100 transmission electron microscope
(JEOL, Tokyo, Japan) in the Kitasato Bio-Imaging Center. Routine
stereological techniques, previously described in detail,25–27,40,47
were used to measure GBM width, Vv(Mes/glom), and Sv(PGBM/
glom). In brief, GBM width was measured using the orthogonal
intercept method,47 Vv(Mes/glom) by point counting, 25–27,40 and
Sv(PGBM/glom) using the line intercept method.27 We calculated
total mesangium per glomerulus (total Mes/glom) and filtration S/G
using the following formulae:
totalMes=glom ¼ MGVVvðMes=glomÞ
filtration S=G ¼ MGVSvðPGBM=glomÞ
Statistical analyses
Data are presented as mean±s.d., except for the UAE rate, which
is presented as the median (range). Values for the UAE were
logarithmically transformed before analysis as they were not normally
distributed. The GFR change during the observational period was
evaluated using linear and nonlinear regression analyses. Relation-
ships between renal structure and function were analyzed using
regression analysis. Statistical significance was regarded as Po0.05.
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